Logo Lanfrica

EPIDEMIOLOGIC INSIGHTS OF KAPOSI SARCOMA AND HUMAN HERPES VIRUS-8 IN TANZANIA: A SCOPING REVIEW

Domaine:

healthcare

Type de record:

paper
Créateur:
IllSumKijMus
Éditeur:
Cen
Éditeur:
OSF
Hôte:avatar
This scoping review summarises the current state of Kaposi sarcoma (KS) and Human Herpesvirus 8 (HHV-8) burden, patient characteristics, diagnosis, and treatment practices in Tanzania. We aimed to identify research gaps and inform practices and policies for better patient outcomes.

Tags

Medicine and Health SciencesKaposi Sarcoma, Human Herpes Virus-8, Tanzania

Licenses

Creative Commons Attribution Non Commercial No Derivatives 4.0 Internationalhttps://creativecommons.org/licenses/by-nc-nd/4.0/legalcode

Similaires

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

International audience Background. We compared Kaposi sarcoma (KS) risk in adults who

Association between malaria exposure and Kaposi's sarcoma‐associated herpes virus seropositivity in Uganda

Abstract Objective Unlike other herpes viruses, Kaposi's sarcoma‐associated herpes virus ( KSHV )

Risk factors for kaposi sarcoma-associated herpesvirus (KSHV) and kaposi sarcoma (KS) mortality in sub-Saharan Africa, The

The largest worldwide burden of Kaposi sarcoma (KS), 85% of all cases, is found in sub-Saharan Afric

Burden of Kaposi sarcoma according to <scp>HIV</scp> status: A systematic review and global analysis

Abstract In 2020, over 34 000 cases of Kaposi sarcoma (KS) were estimated globally, all attributabl

Admitted AIDS-associated Kaposi sarcoma patients

Abstract Kaposi sarcoma (KS) is an AIDS-defining angioproliferative malignancy associa

Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania

Abstract Objectives The Kaposi sarcoma (KS) T0 versus T1 staging classification does not address